Integrated Fluidics Inc., a spin-out from the University of California, Santa Barbara, has developed an electro-kinetic bioassay platform that dramatically improves the performance and cost of time-critical life science research and diagnostic tests.
The iFluidics platform is centered around the revolutionary technology of the iPlate™ Platform and its proprietary software. This technology is compatible with the standard equipment presently being used in labs worldwide.
No other competitor has this ability.
The iFluidics iPlate™ takes the conventional plate and incorporates a circuit board in the bottom of the plate. When the iPlate™ is energized, the electro-kinetic mixing improves processing time up to 70% over conventional plates. In addition to the savings in time, the iFluidics iPlate™ will reduce the amount of blood and reagents per test up to 90%.
Cost per test can be reduced up to 70%
What is the iFluidics iPlate™?The iFluidics iPlate™ takes the conventional microplate used in laboratories around the world and incorporates a circuit board in the bottom of the plate. In conjuction with the iFlluidics patented software, the iPlate™ can reduced the amount of time, blood and reagents resulting in substantial costs per test.
What makes the iPlate™ different from Conventional Microplates?Conventional Microplates Current blood testing uses a conventional microplate with 96 individual wells. A few drops of blood go into each well, followed by expensive reagents that are mixed with the blood. After the reagents are added to the blood, the mixture sits and the lab waits anywhere from 30 minutes to 24 hours for the reaction to occur. iFluidics iPlate™ iFluidics iPlate™ takes the conventional plate and incorporates a circuit board in the bottom of the plate. The iPlate™ circuit board is energized resulting in a more thourough mixing of the reagents and blood through the electromixing in each well.
What are the cost savings for the iPlate™ vs a Conventional Microplate?The Benefits of using the iFluidics iPlate™ Platform are: 75-90% less Blood needed 75-90% less Reagents needed 55-70% less Processing time needed 55-70% less Cost per Test For more details on the cost savings, visit our Investment Portal.
Where can the iFluidics iPlate™ platform be used?Currently the iFluidics iPlate™ platform can be used in Research Labs Life Science Companies Big Pharma Our goal is to get FDA approval by 2022, which will open markets in the Medical and Blood testing fields.